Prostate Cancer Drugs Market Report

Europe Prostate Cancer Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 29, 2019
  • PAGES：177
  • REPORT CODE：GMM416381
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Prostate Cancer Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Prostate Cancer Drugs Market Segmentations:

    By Player:

    • Astra Zeneca

    • Endo Pharmaceuticals

    • Northwest Biotherapeutics

    • GlaxoSmithKline

    • Boehringer Ingelheim

    • Amgen

    • Ferring Pharmaceutical

    • BMS

    • Spectrum Pharmaceuticals

    • Novartis

    • Astellas Pharma

    • Johnson & Johnson

    • Bayer HealthCare

    • Merck Group

    • Teva Pharmaceutical

    • Sanofi

    • Takeda Pharmaceuticals

    • AbbVie

    • Tokai Pharmaceuticals

    • Foresee Pharmaceuticals

    • Janssen Pharmaceuticals

    By Type:

    • Hormonal Therapy

    • Chemotherapy

    • Immunotherapy

    • Targeted Therapy

    By End-User:

    • Clinics

    • Hospitals

    • Other

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Cancer Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Prostate Cancer Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026

    • 1.3.2 Europe Prostate Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

    • 1.3.3 Europe Prostate Cancer Drugs Market Size and Growth Rate of Immunotherapy from 2014 to 2026

    • 1.3.4 Europe Prostate Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Prostate Cancer Drugs Market Size and Growth Rate of Clinics from 2014 to 2026

    • 1.4.2 Europe Prostate Cancer Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.3 Europe Prostate Cancer Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prostate Cancer Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prostate Cancer Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Hormonal Therapy

      • 3.4.2 Market Size and Growth Rate of Chemotherapy

      • 3.4.3 Market Size and Growth Rate of Immunotherapy

      • 3.4.4 Market Size and Growth Rate of Targeted Therapy

    4 Segmentation of Prostate Cancer Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prostate Cancer Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prostate Cancer Drugs for Clinics

      • 4.4.2 Market Size and Growth Rate of Prostate Cancer Drugs for Hospitals

      • 4.4.3 Market Size and Growth Rate of Prostate Cancer Drugs for Other

    5 Market Analysis by Major Regions

    • 5.1 Europe Prostate Cancer Drugs Production Analysis by Top Regions

    • 5.2 Europe Prostate Cancer Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Prostate Cancer Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Prostate Cancer Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Prostate Cancer Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Prostate Cancer Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Prostate Cancer Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prostate Cancer Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Prostate Cancer Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Prostate Cancer Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Prostate Cancer Drugs Landscape Analysis

    • 7.1 Germany Prostate Cancer Drugs Landscape Analysis by Major Types

    • 7.2 Germany Prostate Cancer Drugs Landscape Analysis by Major End-Users

    8. UK Prostate Cancer Drugs Landscape Analysis

    • 8.1 UK Prostate Cancer Drugs Landscape Analysis by Major Types

    • 8.2 UK Prostate Cancer Drugs Landscape Analysis by Major End-Users

    9. France Prostate Cancer Drugs Landscape Analysis

    • 9.1 France Prostate Cancer Drugs Landscape Analysis by Major Types

    • 9.2 France Prostate Cancer Drugs Landscape Analysis by Major End-Users

    10. Italy Prostate Cancer Drugs Landscape Analysis

    • 10.1 Italy Prostate Cancer Drugs Landscape Analysis by Major Types

    • 10.2 Italy Prostate Cancer Drugs Landscape Analysis by Major End-Users

    11. Spain Prostate Cancer Drugs Landscape Analysis

    • 11.1 Spain Prostate Cancer Drugs Landscape Analysis by Major Types

    • 11.2 Spain Prostate Cancer Drugs Landscape Analysis by Major End-Users

    12. Poland Prostate Cancer Drugs Landscape Analysis

    • 12.1 Poland Prostate Cancer Drugs Landscape Analysis by Major Types

    • 12.2 Poland Prostate Cancer Drugs Landscape Analysis by Major End-Users

    13. Russia Prostate Cancer Drugs Landscape Analysis

    • 13.1 Russia Prostate Cancer Drugs Landscape Analysis by Major Types

    • 13.2 Russia Prostate Cancer Drugs Landscape Analysis by Major End-Users

    14. Switzerland Prostate Cancer Drugs Landscape Analysis

    • 14.1 Switzerland Prostate Cancer Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Prostate Cancer Drugs Landscape Analysis by Major End-Users

    15. Turkey Prostate Cancer Drugs Landscape Analysis

    • 15.1 Turkey Prostate Cancer Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Prostate Cancer Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Prostate Cancer Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Prostate Cancer Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Prostate Cancer Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Prostate Cancer Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Prostate Cancer Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Prostate Cancer Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Prostate Cancer Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Prostate Cancer Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Prostate Cancer Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Prostate Cancer Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Prostate Cancer Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Astra Zeneca

      • 19.1.1 Astra Zeneca Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Endo Pharmaceuticals

      • 19.2.1 Endo Pharmaceuticals Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Northwest Biotherapeutics

      • 19.3.1 Northwest Biotherapeutics Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GlaxoSmithKline

      • 19.4.1 GlaxoSmithKline Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Boehringer Ingelheim

      • 19.5.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Amgen

      • 19.6.1 Amgen Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Ferring Pharmaceutical

      • 19.7.1 Ferring Pharmaceutical Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 BMS

      • 19.8.1 BMS Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Spectrum Pharmaceuticals

      • 19.9.1 Spectrum Pharmaceuticals Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Novartis

      • 19.10.1 Novartis Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Astellas Pharma

      • 19.11.1 Astellas Pharma Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Johnson & Johnson

      • 19.12.1 Johnson & Johnson Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Bayer HealthCare

      • 19.13.1 Bayer HealthCare Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Merck Group

      • 19.14.1 Merck Group Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Teva Pharmaceutical

      • 19.15.1 Teva Pharmaceutical Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Sanofi

      • 19.16.1 Sanofi Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Takeda Pharmaceuticals

      • 19.17.1 Takeda Pharmaceuticals Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 AbbVie

      • 19.18.1 AbbVie Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Tokai Pharmaceuticals

      • 19.19.1 Tokai Pharmaceuticals Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Foresee Pharmaceuticals

      • 19.20.1 Foresee Pharmaceuticals Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Janssen Pharmaceuticals

      • 19.21.1 Janssen Pharmaceuticals Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    The List of Tables and Figures (Totals 65 Figures and 125 Tables)

    • Figure Product Picture

    • Figure Europe Prostate Cancer Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026

    • Figure Europe Prostate Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

    • Figure Europe Prostate Cancer Drugs Market Size and Growth Rate of Immunotherapy from 2014 to 2026

    • Figure Europe Prostate Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

    • Figure Europe Prostate Cancer Drugs Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Europe Prostate Cancer Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Prostate Cancer Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Germany Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Prostate Cancer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prostate Cancer Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prostate Cancer Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prostate Cancer Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Hormonal Therapy

    • Figure Market Size and Growth Rate of Chemotherapy

    • Figure Market Size and Growth Rate of Immunotherapy

    • Figure Market Size and Growth Rate of Targeted Therapy

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prostate Cancer Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Other

    • Table Europe Prostate Cancer Drugs Production by Major Regions

    • Table Europe Prostate Cancer Drugs Production Share by Major Regions

    • Figure Europe Prostate Cancer Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Prostate Cancer Drugs Consumption by Major Regions

    • Table Europe Prostate Cancer Drugs Consumption Share by Major Regions

    • Table Germany Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table UK Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table France Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prostate Cancer Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prostate Cancer Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prostate Cancer Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prostate Cancer Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Germany Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table UK Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table France Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table France Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table France Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Italy Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Spain Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Poland Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Russia Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Prostate Cancer Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Prostate Cancer Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Prostate Cancer Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Prostate Cancer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Astra Zeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astra Zeneca

    • Figure Sales and Growth Rate Analysis of Astra Zeneca

    • Figure Revenue and Market Share Analysis of Astra Zeneca

    • Table Product and Service Introduction of Astra Zeneca

    • Table Company Profile and Development Status of Endo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Endo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Endo Pharmaceuticals

    • Table Product and Service Introduction of Endo Pharmaceuticals

    • Table Company Profile and Development Status of Northwest Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Northwest Biotherapeutics

    • Figure Sales and Growth Rate Analysis of Northwest Biotherapeutics

    • Figure Revenue and Market Share Analysis of Northwest Biotherapeutics

    • Table Product and Service Introduction of Northwest Biotherapeutics

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Ferring Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Ferring Pharmaceutical

    • Figure Revenue and Market Share Analysis of Ferring Pharmaceutical

    • Table Product and Service Introduction of Ferring Pharmaceutical

    • Table Company Profile and Development Status of BMS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BMS

    • Figure Sales and Growth Rate Analysis of BMS

    • Figure Revenue and Market Share Analysis of BMS

    • Table Product and Service Introduction of BMS

    • Table Company Profile and Development Status of Spectrum Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals

    • Table Product and Service Introduction of Spectrum Pharmaceuticals

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Bayer HealthCare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare

    • Figure Revenue and Market Share Analysis of Bayer HealthCare

    • Table Product and Service Introduction of Bayer HealthCare

    • Table Company Profile and Development Status of Merck Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Group

    • Figure Sales and Growth Rate Analysis of Merck Group

    • Figure Revenue and Market Share Analysis of Merck Group

    • Table Product and Service Introduction of Merck Group

    • Table Company Profile and Development Status of Teva Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical

    • Table Product and Service Introduction of Teva Pharmaceutical

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Tokai Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tokai Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Tokai Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Tokai Pharmaceuticals

    • Table Product and Service Introduction of Tokai Pharmaceuticals

    • Table Company Profile and Development Status of Foresee Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Foresee Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Foresee Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Foresee Pharmaceuticals

    • Table Product and Service Introduction of Foresee Pharmaceuticals

    • Table Company Profile and Development Status of Janssen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals

    • Table Product and Service Introduction of Janssen Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US